Although the clinical data do not support the initial suggestion from CCLE data that ERBB4 copy number loss is associated with GBM, it may be possible that loss in intron 1 of the ERBB4 gene is a factor that increases the risk that an individual will develop GBM. The gene discussed is ERBB4; the disease is glioblastoma.